[PRESS RELEASE – Hong Kong, China, October 31st, 2024]
The web3 firm accelerates APAC expansion, welcoming new leadership to drive growth and adoption across Asia.
Serotonin, the global web3 firm bringing breakthrough technologies to market, is pleased to announce its expansion into APAC with the launch of its Hong Kong-based marketing practice, Serotonin’s first dedicated services operation in Asia. Over the last year, Serotonin has invested in scaling its APAC operations, growing its team of go-to-market experts to build an APAC practice that represents 20% of Serotonin’s marketing business. Serotonin is a key partner for Eastern-originated projects expanding into global markets. Simultaneously, Serotonin extends its core services to Western web3 companies seeking APAC market entry.
As part of the expansion into Hong Kong, Serotonin is pleased to announce Caroline York as its newest APAC Marketing Director. With over a decade of experience in brand strategy and marketing communications, York has held leadership roles at Asia’s leading fintech and brand technology firms, including Gusto Collective and AQUMON. As Director of Marketing at Gusto Collective, she pioneered blockchain and web3 solutions for luxury brands, and currently serves as the co-chair of the Fintech Association of Hong Kong’s Web3 & Blockchain Committee. In her role at Serotonin, York will leverage her deep expertise in fintech and marketing to support the firm’s APAC expansion, acting as a strategic partner for clients navigating the web3 landscape.
“The APAC region is capturing global attention for its growth in web3 activity and ambitious stated goals,” said Caroline York, APAC Marketing Director at Serotonin. “With its diverse, young, tech-savvy populations and proactive regulatory frameworks, Asia is set to lead in the web3 landscape. Serotonin’s expansion here is a strong industry signal of the tremendous opportunities ahead. I’m excited to bring our global best practices here, unlocking unprecedented value for projects ready to drive the next wave of web3 acceleration.”
Serotonin is the premier services firm for transformative technologies, offering marketing, strategy, recruiting and legal as its core services. Serotonin has a global workforce of 90 team members in 15 countries. Since launching in 2020, Serotonin has worked with 300 clients across consumer tech, web3 infrastructure, digital assets, venture capital, and AI, and recently supported APAC-based projects like Memeland, Galxe, and Mawari. In bringing its practice to Asia, Serotonin offers comprehensive go-to-market services across all major marketing channels, including public relations, growth marketing, onchain analytics, content, research, social, and design.
“We see significant growth opportunities as projects and teams in our space become increasingly interconnected with users and developers worldwide,” said Amanda Cassatt, Founder and CEO of Serotonin. “Once we develop a thesis—such as our positive outlook on the APAC region—we act swiftly, transforming our insights into creative and powerful ways to support our partners.”
About Serotonin
Serotonin brings the world’s breakthrough technologies to market. Serotonin’s core offerings include marketing, strategy, recruiting, and legal services. The Serotonin Platform is a go-to hub for the web3 ecosystem, connecting builders and founders and providing industry resources for business acceleration.
About the Founder
Serotonin CEO & Founder Amanda Cassatt is one of the original crypto marketers. Cassatt published the first book on web3 marketing in April 2023, defining the fundamentals of community growth and how web3 transforms time-tested approaches to product marketing and brand-building. In her prior role as CMO at ConsenSys, Cassatt built one of the industry’s first marketing teams and played a fundamental role in elevating blockchain technology on the global stage. In 2020, Amanda founded Serotonin to offer the best in class go-to-market services for transformative technologies.
For more information, users can visit Serotonin.co and join the Serotonin Platform today.
Read the full article here